Great Ajax (NYSE:AJX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.11 by 27.27 percent. This is a 63.16 percent decrease over earnings of $0.38 per share from the same period last year.
10-Year Phase 3 Trial Shows CEL-SCI’s Multikine immunotherapy Extends Lives In Head & Neck Cancer Patients
CEL-SCI Corporation (NYSE:CVM) said that its 10-year Phase 3 trial showed that Multikine immunotherapy significantly extended the lives of patients with…